Fereshteh Esfandiari

Fereshteh Esfandiari

Auto-generated profile, based on publicly available information

Fereshteh Esfandiari

Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2012 in Stem Cells and Development
Verified
Journal Article
Closed access
FEFereshteh Esfandiari
Fereshteh Esfandiari
AFAli Fathi
Ali Fathi
HGHamid Gourabi
Hamid Gourabi
SKSahar Kiani
Sahar Kiani
SNShiva Nemati
Shiva Nemati
HBHossein Baharvand
Hossein Baharvand
Human-induced pluripotent stem cell-derived neural progenitors (hiPSC-NPs) have the ability to self-renew and differentiate into glial and neuronal lineages, which makes them an invaluable source in cell replacement therapy for neurological diseases. Therefore, their enhanced proliferation and neuronal differentiation are pivotal features that can be used in repairing neurological injuries. One of the main regulators of neural development is Wnt signaling, which results in the inhibition of glycogen synthase kinase 3 (GSK-3). Here, we assess the impact of GSK-3 inhibition by the small molecule CHIR99021 on the expansion and differentiation of hiPSC-NPs in an adherent condition and a defined medium. Cell proliferation analyses have revealed that inhibition of GSK-3 in the presence of epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF) increased the proliferation of hiPSC-NPs across 10 passages. The inhibition of β-catenin signaling by XAV and NOTCH signaling by DAPT reversed CHIR impact on hiPSC-NPs proliferation. The target genes of β-catenin, C-MYC and CYCLIN D1 as well as NOTCH target genes, HES1 and HES5 were upregulated. The treatment of NPs by CHIR in the absence of bFGF and EGF resulted in an increase of neuronal differentiation rather than proliferation by stabilization of β-catenin regardless of the NOTCH pathway. Thus, GSK-3 inhibition has been shown to promote proliferation of the NPs by activating β-catenin and NOTCH-related cell cycle genes in the presence of bFGF and EGF. Additionally, during GSK-3 inhibition, an absence of these growth factors allows for the switch to neuronal differentiation with a bias toward a dopaminergic fate. This may provide desired cells that can be used in therapeutic applications and offer insights into the etiology of some neurological disorders.

1 February 2021 in Toxicology in Vitro
Verified
Journal Article
Closed access
MSMaryam Saber
Maryam Saber
RHReyhaneh-Sadat Hayaei-Tehrani
Reyhaneh-Sadat Hayaei-Tehrani
SMSaadat Mokhtari
Saadat Mokhtari
PHParisa Hoorzad
Parisa Hoorzad
FEFereshteh Esfandiari
Fereshteh Esfandiari

17 October 2016 in Macromolecular Bioscience
Verified
Journal Article
Closed access
PDF file
FEFereshteh Esfandiari
Fereshteh Esfandiari
MAMohammad Kazemi Ashtiani
Mohammad Kazemi Ashtiani
MSMehdi Sharifi‐Tabar
Mehdi Sharifi‐Tabar
MSMaryam Saber
Maryam Saber
HDHamed Daemi
Hamed Daemi
HBHossein Baharvand
Hossein Baharvand

22 September 2018 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
SMSeyedeh‐Faezeh Moraveji
Seyedeh‐Faezeh Moraveji
FEFereshteh Esfandiari
Fereshteh Esfandiari
MSMina Sharbatoghli
Mina Sharbatoghli
STSara Taleahmad
Sara Taleahmad
SNSaman Nikeghbalian
Saman Nikeghbalian
HBHossein Baharvand
Hossein Baharvand

1 December 2019 in Human Reproduction
Verified
Journal Article
Closed access
SMSeyedeh-Faezeh Moraveji
Seyedeh-Faezeh Moraveji
FEFereshteh Esfandiari
Fereshteh Esfandiari
STSara Taleahmad
Sara Taleahmad
SNSaman Nikeghbalian
Saman Nikeghbalian
FSForough-Azam Sayahpour
Forough-Azam Sayahpour
HBHossein Baharvand
Hossein Baharvand
STUDY QUESTION: Could small molecules (SM) which target (or modify) signaling pathways lead to increased proliferation of undifferentiated spermatogonia following chemotherapy?SUMMARY ANSWER: Inhibition of transforming growth factor-beta (TGFb) signaling by SM can enhance the proliferation of undifferentiated spermatogonia and spermatogenesis recovery following chemotherapy.WHAT IS KNOWN ALREADY: Spermatogonial stem cells (SSCs) hold great promise for fertility preservation in prepubertal boys diagnosed with cancer. However, the low number of SSCs limits their clinical applications. SM are chemically synthesized molecules that diffuse across the cell membrane to specifically target proteins involved in signaling pathways, and studies have reported their ability to increase the proliferation or differentiation of germ cells.STUDY DESIGN, SIZE, DURATION: In our experimental study, spermatogonia were collected from four brain-dead individuals and used for SM screening in vitro. For in vivo assessments, busulfan-treated mice were treated with the selected SM (or vehicle, the control) and assayed after 2 (three mice per group) and 5 weeks (two mice per group).PARTICIPANTS/MATERIALS, SETTING, METHODS: We investigated the effect of six SM on the proliferation of human undifferentiated spermatogonia in vitro using a top–bottom approach for screening. We used histological, hormonal and gene-expression analyses to assess the effect of selected SM on mouse spermatogenesis. All experiments were performed at least in triplicate and were statistically evaluated by Student’s t-test and/or one-way ANOVA followed by Scheffe’s or Tukey’s post-hoc.MAIN RESULTS AND THE ROLE OF CHANCE: We found that administration of SB431542, as a specific inhibitor of the TGFb1 receptor (TGFbR1), leads to a two-fold increase in mouse and human undifferentiated spermatogonia proliferation. Furthermore, injection of SB to busulfan-treated mice accelerated spermatogenesis recovery as revealed by increased testicular size, weight and serum level of inhibin B. Moreover, SB administration accelerated both the onset and completion of spermatogenesis. We demonstrated that SB promotes proliferation in testicular tissue by regulating the cyclin-dependent kinase (CDK) inhibitors 4Ebp1 and P57 (proliferation inhibitor genes) and up-regulating Cdc25a and Cdk4 (cell cycle promoting genes).LIMITATIONS, REASONS FOR CAUTION: The availability of human testis was the main limitation in this study.WIDER IMPLICATIONS OF THE FINDINGS: This is the first study to report acceleration of spermatogenesis recovery following chemotherapy by administration of a single SM. Our findings suggest that SB is a promising SM and should be assessed in future clinical trials for preservation of fertility in men diagnosed with cancer or in certain infertility cases (e.g. oligospermia).STUDY FUNDING/COMPETING INTEREST(S): This study was supported by Royan Institute and National Institute for Medical Research Development (NIMAD, grant no 963337) granted to H.B. The authors have no conflict of interest to report.

18 May 2023 in Lab on a Chip
Verified
Journal Article
Closed access
PDF file
EDEhsan Dadkhah
Ehsan Dadkhah
MHMohammad Amin Hajari
Mohammad Amin Hajari
SASeyedamirhosein Abdorahimzadeh
Seyedamirhosein Abdorahimzadeh
ASAbdolhossein Shahverdi
Abdolhossein Shahverdi
FEFereshteh Esfandiari
Fereshteh Esfandiari
LMLeila Montazeri
Leila Montazeri
Improved sperm selection in microchannels by introducing curved geometries. Sharper curvatures enhance the quality of selected sperms. The selection is based on sperm boundary following characteristic and a gentle backflow in the microchannel.